Strides Reports 16.7percentage YoY Revenue Growth in Q1FY25, Reaches INR10,875M
New Delhi, India, July 30, 2024: Strides Pharma Science Ltd . announced its consolidated financial results for the quarter (Q1FY25) ended June 30, 2024. Adjusted PAT = PAT from continuing operations without JV share and exceptional […]